Stiripentol. Severe myoclonic epilepsy of infancy: Promising

Prescrire International

Volumn 14, Issue 76, 2005, Pages 57-59

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CAFFEINE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CYCLOSPORIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 3A4; PLACEBO; RAPAMYCIN; STIRIPENTOL; TACROLIMUS; THEOPHYLLINE; VALPROIC ACID; 1,3 DIOXOLANE DERIVATIVE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; NEW DRUG;

ADOLESCENT; ADULT; AGGRESSION; ANOREXIA; ARTICLE; ATAXIA; BODY WEIGHT; BODY WEIGHT DISORDER; CHILD; CHILD CARE; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG POTENTIATION; ENZYME INHIBITION; FOLLOW UP; FRANCE; HUMAN; HYPERACTIVITY; INFANT; INSOMNIA; MENTAL DEFICIENCY; META ANALYSIS; MUSCLE HYPOTONIA; MYOCLONUS EPILEPSY; NONHUMAN; PATIENT MONITORING; PSYCHOMOTOR DEVELOPMENT; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION; DOUBLE BLIND PROCEDURE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTICONVULSANTS; BENZODIAZEPINES; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DIOXOLANES; DOUBLE-BLIND METHOD; DRUGS, INVESTIGATIONAL; EPILEPSIES, MYOCLONIC; FRANCE; HUMANS; INFANT; VALPROIC ACID;

EID: 18244402913     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chiron C and Dulac O "Les différents syndromes épileptiques chez le nourrisson". In: "Les médicaments antiépileptiques chez l'enfant" Springer-Verlag, Paris 1994: 47-55.
2. Prescrire Rédaction "Épilepsies généralisées" Rev Prescrire 2003; 23 (236): 124-126.
3. Astoin J et al. "Action de nouveaux alcools alpha-éthyléniques sur le système nerveux central" Eur J Med Chem Chim 1978; 13 (1): 41-47.
4. Poisson M et al. "A new type of anticonvulsivant, stiripentol. Pharmacological profile and neurochemical study" Arzneim-Forsch Drug Res 1984, 34: 199-204.
5. Lockard JS et al. "Stiripentol in acute/chronic efficacy tests in monkey model" Epilepsia 1985; 26 (6): 704-712.
6. Shen DD et al. "Efficacy of stiripentol in the intravenous pentylenetetrazol infusion seizure model in the rat" Epilepsy Res 1990; 7: 40-48.
7. Perez C et al. "Stiripentol: efficacy and tolerability in children with epilepsy" Epilepsia 1999; 40 (11): 1618-1626.
8. Chiron C et al. "Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial" Lancet 2000; 356: 1638-1642.
9. Nguyen Thanh T et al. "Efficacité et tolérance à long terme du stiripentol dans le traitement de l'épilepsie myoclonique sév_gere du nourrisson (syndrome de Dravet)" Arch Pediatr 2002; 9: 1120-1127.
10. Tran A et al. "Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants" Clin Pharmacol Ther 1997; 62 (5): 490-404.
11. Billard C et al. "Le stiripentol: expérience chez l'enfant". In: "Les médicaments antiépileptiques chez l'enfant" Springer-Verlag, Paris 1994: 227-238.
12. The European Agency for the Evaluation of Medicinal Products "19th meeting of the Committee for Orphan Medicinal Products-Press release" 19 December 2001. Website http://www.emea.eu.int consulted on 7 July 2004.